COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 84: Articles 831-840  | Next

'Trans-differentiation of neutrophils from plasmablast' is an artefact caused by over-reliance on machine algorithms in single cell RNA sequencing analysis: Lesson learnt and steps ahead
Huang, J., Yam, P. S. C., Tang, N. L.-s.
10.1101/2025.02.07.636761 — Posted: 2025-02-07
DAZAP2 functions as a pan-coronavirus restriction factor by inhibiting viral entry and genomic replication
Feng, F., Chen, J., Li, R., Zhu, Y., Ma, Y., Wang, Z., Wang, Y., Gao, Z., Yang, L., Yu, Y., Liu, Y., Sun, Y., Liao, Y., Huang, X., Zhang, Q., Huang, Y., Qiu, L., Wu, J., Zhao, J., Liu, C., Ding, Q., Xie, Y., Yuan, Z., Hong, Y., Zhang, P., Sun, J., Zhao, J., Zhang, R.
10.1101/2025.02.04.636569 — Posted: 2025-02-07
Reproducibility of Genetic Risk Factors Identified for Long COVID using Combinatorial Analysis Across US and UK Patient Cohorts with Diverse Ancestries
Sardell, J., Pearson, M., Chocian, K., Das, S., Taylor, K., Strivens, M., Gupta, R., Rochlin, A., Gardner, S.
10.1101/2025.02.04.25320937 — Posted: 2025-02-06
Longitudinal evaluation of anti-SARS-CoV-2 neutralizing antibody levels in 3-dose homologous (mRNA-1273- mRNA-1273- BNT162b2) vaccinated Kidney transplant population: 18-month follow-up.
Karunathilake, R. P., Kumara, A., Karunathilake, A., Wazil, A. W., Nanayakkara, N., Bandara, K., Abeysekara, R., Noordeen, F., Gawarammana, I. B., Ratnatunga, C. N.
10.1101/2025.02.05.25321720 — Posted: 2025-02-06
P3a site-specific or cassette mutagenesis for seamless protein and plasmid engineering
Yang, X.-J.
10.1101/2025.02.03.636246 — Posted: 2025-02-06
Impact of Ebola and COVID-19 pandemic on patterns in uptake of short-acting and long-acting contraceptive methods in Sierra Leone: a country-wide observational study
Kamara, I. M., Molleh, B., Lakoh, S., Sevalie, S., Kenneh, S. M., Chan, A. K., Mishra, S., Moses, F., Bah, A. J.
10.1101/2025.02.04.25321692 — Posted: 2025-02-05
Adjusting for residual confounding using high-dimensional propensity scores in a study of inhaled corticosteroids and COVID-19 outcomes
Bokern, M., Tazare, J., Rentsch, C. T., Quint, J. K., Douglas, I. J., Schultze, A.
10.1101/2025.02.04.25321459 — Posted: 2025-02-05
Vaccine Hesitancy, Coercion and Regret: Post-Pandemic Lessons on COVID-19 Vaccine Policies and Outreach among Newcomer Communities in Alberta, Canada
Antonio, M., Cerino, E. R.-, Sahilie, A., Yemane, M., Youssef, M., Nielssen, I., Holdbrook, L., Essar, M. Y., Santana, M., Spitzer, D., Pottie, K., Fabreau, G. E.
10.1101/2025.02.03.25320914 — Posted: 2025-02-05
Post-Viral Frailty in Long COVID: A Distinct Phenotype within Veterans
Bradley, J., Bast, E., Resendes, N. M., Tang, F., Cevallos, V. D., Tosi, D. M., Tamariz, L., Palacio, A., Hammel, I.
10.1101/2025.02.04.25321653 — Posted: 2025-02-05
CONVEX VERSUS LINEAR TRANSDUCER IN COVID-19 LUNG ULTRASOUND: A PROSPECTIVE COMPARATIVE COHORT
Gil-Rodriguez, J., Peregrina-Rivas, J. A., Aranda-Laserna, P., Martos-Ruiz, M., Montero-Alonso, M. A., Benavente-Fernandez, A., Melchor, J., Guirao-Arrabal, E., Hernandez-Quero, J.
10.1101/2025.01.31.25321454 — Posted: 2025-02-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).